{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:38:14Z","timestamp":1792723094115,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neurot.2026.e01056","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:54:46Z","timestamp":1789674886000},"page":"e01056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["New approach methodologies in neurotherapeutics development"],"prefix":"10.1016","volume":"23","author":[{"given":"Amir P.","family":"Tamiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szczepan W.","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy W.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2026.e01056_bib1","first-page":"1","article-title":"Established and emerging new approach methodologies in neuroscience. Sec. Neuroscience methods and techniques","author":"Imberechts","year":"2025","journal-title":"Front Neurosci"},{"issue":"6796","key":"10.1016\/j.neurot.2026.e01056_bib2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.aeb0045","article-title":"Reimagining human-centric drug development with new approach methodologies","volume":"392","author":"Wu","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.neurot.2026.e01056_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41573-020-0079-3","article-title":"Organs-on-chips: into the next decade","volume":"20","author":"Low","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neurot.2026.e01056_bib4","article-title":"Assembling human brain organoids","volume":"375","author":"Pa\u015fca","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.neurot.2026.e01056_bib5","article-title":"Complement-ARIE: catalyzing the development and adoption of new approach methodologies","volume":"1","author":"Sunderic","year":"2025","journal-title":"NAMTA J"},{"issue":"10","key":"10.1016\/j.neurot.2026.e01056_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.neurot.2026.e01056_bib7","series-title":"Guidance document on good in vitro method practices (GIVIMP). OECD series on testing and assessment no. 286","year":"2018"},{"key":"10.1016\/j.neurot.2026.e01056_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14573\/altex.1609122","article-title":"A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity","volume":"34","author":"Pamies","year":"2017","journal-title":"ALTEX"},{"key":"10.1016\/j.neurot.2026.e01056_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1616470","article-title":"Microglia-containing neural organoids as brain microphysiological systems for long-term culture","volume":"19","author":"Rittenhouse","year":"2025","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.neurot.2026.e01056_bib11","doi-asserted-by":"crossref","DOI":"10.1289\/EHP8580","article-title":"Gene-environment interactions in developmental neurotoxicity: a case study of synergy between chlorpyrifos and CHD8 knockout in human BrainSpheres","volume":"129","author":"Modafferi","year":"2021","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.neurot.2026.e01056_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fsci.2023.1017235","article-title":"Organoid intelligence (OI): the new frontier in biocomputing and intelligence-in-a-dish","volume":"1","author":"Smirnova","year":"2023","journal-title":"Front Sci"},{"key":"10.1016\/j.neurot.2026.e01056_bib13","first-page":"30","article-title":"Guidance document on good cell and tissue culture practice 2.0 (GCCP 2.0)","volume":"39","author":"Pamies","year":"2022","journal-title":"ALTEX"},{"key":"10.1016\/j.neurot.2026.e01056_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/toxsci\/kfy152","article-title":"Machine learning of toxicological big data enables read-across structure activity relationships (RASAR) outperforming animal test reproducibility","volume":"165","author":"Luechtefeld","year":"2018","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e01056_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/toxsci\/kfl103","article-title":"The ToxCast program for prioritizing toxicity testing of environmental chemicals","volume":"95","author":"Dix","year":"2007","journal-title":"Toxicol Sci"},{"issue":"7","key":"10.1016\/j.neurot.2026.e01056_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neurot.2026.e01056_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2016.03.021","article-title":"The need for new approaches in CNS drug discovery: why drugs have failed, and what can be done to improve outcomes","volume":"120","author":"Gribkoff","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurot.2026.e01056_bib18","series-title":"FDA modernization Act 2.0, S.5002, 117th Cong","first-page":"117","year":"2022"},{"key":"10.1016\/j.neurot.2026.e01056_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/d41573-020-00030-2","article-title":"Opportunities and challenges with microphysiological systems: a pharma end-user perspective","volume":"20","author":"Ewart","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01056_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202300131","article-title":"Considerations from an international regulatory and pharmaceutical industry (IQ MPS Affiliate) workshop on the standardization of complex in vitro models in drug development","volume":"8","author":"Tomlinson","year":"2024","journal-title":"Adv Biol"},{"key":"10.1016\/j.neurot.2026.e01056_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104592","article-title":"An evaluation framework for new approach methodologies (NAMs) for human health safety assessment","volume":"112","author":"Parish","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"issue":"11","key":"10.1016\/j.neurot.2026.e01056_bib22","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s00204-022-03365-4","article-title":"A framework for establishing scientific confidence in new approach methodologies","volume":"96","author":"van der Zalm","year":"2022","journal-title":"Arch Toxicol"},{"issue":"8","key":"10.1016\/j.neurot.2026.e01056_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104058","article-title":"50 shades of AI in regulatory science","volume":"29","author":"Tong","year":"2024","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.neurot.2026.e01056_bib24","first-page":"297","article-title":"Perspectives on the evaluation and adoption of complex in vitro models in drug development: workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate)","volume":"39","author":"Baran","year":"2022","journal-title":"ALTEX"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926002266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:53:14Z","timestamp":1792720394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926002266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1878747926002266"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01056","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New approach methodologies in neurotherapeutics development","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e01056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e01056"}}